To predict the efficacy of hormonal therapy for breast cancer at the level of the individual, immunohistochemical methods are used to analyze classical molecular biomarkers such as estrogen receptor (ER), progesterone receptor (PgR), and HER2 [1–3]. Here, PGR is linked to breast cancer.